{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T16:20:33Z","timestamp":1787588433283,"version":"build-2736575974"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T00:00:00Z","timestamp":1785628800000},"content-version":"vor","delay-in-days":213,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005892","name":"China Academy of Chinese Medical Sciences","doi-asserted-by":"publisher","award":["2022s471"],"award-info":[{"award-number":["2022s471"]}],"id":[{"id":"10.13039\/501100005892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005892","name":"China Academy of Chinese Medical Sciences","doi-asserted-by":"publisher","award":["CI2026A02212"],"award-info":[{"award-number":["CI2026A02212"]}],"id":[{"id":"10.13039\/501100005892","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["BBA Advances"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.bbadva.2026.100199","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T06:30:11Z","timestamp":1785738611000},"page":"100199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Mitochondrial convergence of ferroptosis and cuproptosis in castration-resistant prostate cancer: From metabolic vulnerabilities to therapeutic targeting"],"prefix":"10.1016","volume":"10","author":[{"given":"Can-lin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-ting","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-qi","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.bbadva.2026.100199_bib0001","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14093067","article-title":"Prostate cancer-research advances in early detection","volume":"14","author":"Czerw","year":"2025","journal-title":"J. Clin. Med."},{"issue":"10437","key":"10.1016\/j.bbadva.2026.100199_bib0002","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S0140-6736(24)00651-2","article-title":"The Lancet commission on prostate cancer: planning for the surge in cases","volume":"403","author":"James","year":"2024","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.bbadva.2026.100199_bib0003","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S1470-2045(14)71205-7","article-title":"Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study","volume":"16","author":"Ryan","year":"2015","journal-title":"Lancet Oncol."},{"issue":"8","key":"10.1016\/j.bbadva.2026.100199_bib0004","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.1007\/s12325-021-01823-6","article-title":"Real-world treatment patterns and overall survival of patients with metastatic castration-resistant prostate cancer in the US prior to PARP inhibitors","volume":"38","author":"Shore","year":"2021","journal-title":"Adv. Ther."},{"issue":"6","key":"10.1016\/j.bbadva.2026.100199_bib0005","doi-asserted-by":"crossref","DOI":"10.3390\/cancers9060067","article-title":"Androgen receptor-dependent and -independent mechanisms involved in prostate cancer therapy resistance","volume":"9","author":"Crona","year":"2017","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.bbadva.2026.100199_bib0006","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15041192","article-title":"Unraveling the peculiar features of mitochondrial metabolism and dynamics in prostate cancer","volume":"15","author":"Fontana","year":"2023","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.bbadva.2026.100199_bib0007","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/s41416-024-02762-z","article-title":"Metabolic adaptations in prostate cancer","volume":"131","author":"Pujana-Vaquerizo","year":"2024","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.bbadva.2026.100199_bib0008","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1080\/15548627.2024.2319901","article-title":"International consensus guidelines for the definition, detection, and interpretation of autophagy-dependent ferroptosis","volume":"20","author":"Chen","year":"2024","journal-title":"Autophagy"},{"issue":"6586","key":"10.1016\/j.bbadva.2026.100199_bib0009","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.abf0529","article-title":"Copper induces cell death by targeting lipoylated TCA cycle proteins","volume":"375","author":"Tsvetkov","year":"2022","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.bbadva.2026.100199_bib0010","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cell.2016.12.039","article-title":"Understanding the intersections between metabolism and cancer biology","volume":"168","author":"Vander Heiden","year":"2017","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.bbadva.2026.100199_bib0011","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.molcel.2016.02.011","article-title":"Mitochondria and cancer","volume":"61","author":"Zong","year":"2016","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.bbadva.2026.100199_bib0012","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s13238-017-0451-1","article-title":"The emerging role and targetability of the TCA cycle in cancer metabolism","volume":"9","author":"Anderson","year":"2018","journal-title":"Protein Cell"},{"issue":"1","key":"10.1016\/j.bbadva.2026.100199_bib0013","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12943-017-0646-3","article-title":"Emerging roles of lipid metabolism in cancer metastasis","volume":"16","author":"Luo","year":"2017","journal-title":"Mol. Cancer"},{"issue":"12","key":"10.1016\/j.bbadva.2026.100199_bib0014","doi-asserted-by":"crossref","DOI":"10.3390\/cells9122600","article-title":"The role of mitochondrial fat oxidation in cancer cell proliferation and survival","volume":"9","author":"De Oliveira","year":"2020","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.bbadva.2026.100199_bib0015","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.trecan.2017.01.005","article-title":"Glutamine metabolism in cancer: understanding the heterogeneity","volume":"3","author":"Cluntun","year":"2017","journal-title":"Trends Cancer"},{"issue":"3","key":"10.1016\/j.bbadva.2026.100199_bib0016","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cmet.2020.06.019","article-title":"Mitochondrial metabolism as a target for cancer therapy","volume":"32","author":"Vasan","year":"2020","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.bbadva.2026.100199_bib0017","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/s41467-018-03573-6","article-title":"Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression","volume":"9","author":"Latonen","year":"2018","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.bbadva.2026.100199_bib0018","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/ijc.31313","article-title":"Metabolomics and transcriptomics profiles reveal the dysregulation of the tricarboxylic acid cycle and related mechanisms in prostate cancer","volume":"143","author":"Shao","year":"2018","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.bbadva.2026.100199_bib0019","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/s41585-020-0288-x","article-title":"Tumour metabolism and its unique properties in prostate adenocarcinoma","volume":"17","author":"Bader","year":"2020","journal-title":"Nat. Rev. Urol."},{"issue":"4","key":"10.1016\/j.bbadva.2026.100199_bib0020","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrurol.2013.43","article-title":"Zinc and zinc transporters in prostate carcinogenesis","volume":"10","author":"Kolenko","year":"2013","journal-title":"Nat. Rev. Urol."},{"issue":"1","key":"10.1016\/j.bbadva.2026.100199_bib0021","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/1476-4598-12-145","article-title":"High mitochondria content is associated with prostate cancer disease progression","volume":"12","author":"Grupp","year":"2013","journal-title":"Mol. Cancer"},{"issue":"12","key":"10.1016\/j.bbadva.2026.100199_bib0022","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/pros.24146","article-title":"Prostate cancer cells survive anti-androgen and mitochondrial metabolic inhibitors by modulating glycolysis and mitochondrial metabolic activities","volume":"81","author":"Basu","year":"2021","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.bbadva.2026.100199_bib0023","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/jcp.2005.027664","article-title":"Altered metabolism and mitochondrial genome in prostate cancer","volume":"59","author":"Dakubo","year":"2006","journal-title":"J. Clin. Pathol."},{"issue":"2","key":"10.1016\/j.bbadva.2026.100199_bib0024","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41588-017-0026-3","article-title":"Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer","volume":"50","author":"Chen","year":"2018","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.bbadva.2026.100199_bib0025","doi-asserted-by":"crossref","DOI":"10.15252\/msb.20199247","article-title":"STAT3-dependent analysis reveals PDK4 as independent predictor of recurrence in prostate cancer","volume":"16","author":"Oberhuber","year":"2020","journal-title":"Mol. Syst. Biol."},{"issue":"24","key":"10.1016\/j.bbadva.2026.100199_bib0026","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413435","article-title":"Targeting mitochondrial OXPHOS and their regulatory signals in prostate cancers","volume":"22","author":"Chen","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bbadva.2026.100199_bib0027","doi-asserted-by":"crossref","DOI":"10.3390\/metabo11030139","article-title":"Resistance to androgen deprivation leads to altered metabolism in human and murine prostate cancer cell and tumor models","volume":"11","author":"Sun","year":"2021","journal-title":"Metabolites"},{"issue":"9","key":"10.1016\/j.bbadva.2026.100199_bib0028","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/s41416-021-01435-5","article-title":"Metabolic reprogramming in prostate cancer","volume":"125","author":"Ahmad","year":"2021","journal-title":"Br. J. Cancer"},{"issue":"45","key":"10.1016\/j.bbadva.2026.100199_bib0029","doi-asserted-by":"crossref","first-page":"5251","DOI":"10.1038\/onc.2013.463","article-title":"Androgens regulate prostate cancer cell growth via an AMPK-PGC-1\u03b1-mediated metabolic switch","volume":"33","author":"Tennakoon","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.bbadva.2026.100199_bib0030","article-title":"Personalized medicine for prostate cancer: is targeting metabolism a reality?","volume":"11","author":"Fidelito","year":"2021","journal-title":"Front. Oncol."},{"issue":"44","key":"10.1016\/j.bbadva.2026.100199_bib0031","doi-asserted-by":"crossref","first-page":"6284","DOI":"10.1038\/s41388-021-02008-9","article-title":"Prostate cancer castrate resistant progression usage of non-canonical androgen receptor signaling and ketone body fuel","volume":"40","author":"Labanca","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.bbadva.2026.100199_bib0032","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.semcancer.2017.04.005","article-title":"Mitochondrial ROS control of cancer","volume":"47","author":"Idelchik","year":"2017","journal-title":"Semin. Cancer Biol."},{"issue":"6","key":"10.1016\/j.bbadva.2026.100199_bib0033","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1085\/jgp.201210772","article-title":"Glutathione\/thioredoxin systems modulate mitochondrial H2O2 emission: an experimental-computational study","volume":"139","author":"Aon","year":"2012","journal-title":"J. Gen. Physiol."},{"issue":"4","key":"10.1016\/j.bbadva.2026.100199_bib0034","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/bjc.2013.396","article-title":"Peroxiredoxin-3 is overexpressed in prostate cancer and promotes cancer cell survival by protecting cells from oxidative stress","volume":"109","author":"Whitaker","year":"2013","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.bbadva.2026.100199_bib0035","first-page":"96","article-title":"Oxidative stress and redox signaling in CRPC progression: therapeutic potential of clinically-tested Nrf2-activators","volume":"4","author":"Mondal","year":"2021","journal-title":"Cancer Drug Resist."},{"issue":"13","key":"10.1016\/j.bbadva.2026.100199_bib0036","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1038\/emboj.2011.158","article-title":"The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis","volume":"30","author":"Massie","year":"2011","journal-title":"Embo J."},{"issue":"12","key":"10.1016\/j.bbadva.2026.100199_bib0037","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1101\/gad.299958.117","article-title":"Nuclear mTOR acts as a transcriptional integrator of the androgen signaling pathway in prostate cancer","volume":"31","author":"Audet-Walsh","year":"2017","journal-title":"Genes Dev."},{"key":"10.1016\/j.bbadva.2026.100199_bib0038","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.580617","article-title":"Androgen receptor signaling and metabolic and cellular plasticity during progression to castration resistant prostate cancer","volume":"10","author":"Uo","year":"2020","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.bbadva.2026.100199_bib0039","doi-asserted-by":"crossref","first-page":"T57","DOI":"10.1530\/ERC-13-0515","article-title":"Androgen-regulated metabolism and biosynthesis in prostate cancer","volume":"21","author":"Barfeld","year":"2014","journal-title":"Endocr. Relat. Cancer"},{"issue":"10","key":"10.1016\/j.bbadva.2026.100199_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113221","article-title":"MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer","volume":"42","author":"Crowell","year":"2023","journal-title":"Cell Rep."},{"issue":"30","key":"10.1016\/j.bbadva.2026.100199_bib0041","article-title":"Enzalutamide sensitizes castration-resistant prostate cancer to copper-mediated cell death","volume":"11","author":"Gao","year":"2024","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.bbadva.2026.100199_bib0042","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/2049-3002-2-17","article-title":"Mitochondrial reactive oxygen species and cancer","volume":"2","author":"Sullivan","year":"2014","journal-title":"Cancer Metab."},{"key":"10.1016\/j.bbadva.2026.100199_bib0043","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cca.2020.12.005","article-title":"Mitochondrial iron metabolism and its role in diseases","volume":"513","author":"Gao","year":"2021","journal-title":"Clin. Chim. Acta"},{"issue":"3","key":"10.1016\/j.bbadva.2026.100199_bib0044","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1042\/BST20160139","article-title":"Mitochondrial cytochrome c oxidase: catalysis, coupling and controversies","volume":"45","author":"Rich","year":"2017","journal-title":"Biochem. Soc. Trans."},{"issue":"7\u20139","key":"10.1016\/j.bbadva.2026.100199_bib0045","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ejcb.2015.05.002","article-title":"The role of mitochondria and the CIA machinery in the maturation of cytosolic and nuclear iron-sulfur proteins","volume":"94","author":"Lill","year":"2015","journal-title":"Eur. J. Cell Biol."},{"issue":"4","key":"10.1016\/j.bbadva.2026.100199_bib0046","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41419-024-06691-w","article-title":"The crosstalk between mitochondrial quality control and metal-dependent cell death","volume":"15","author":"Zhou","year":"2024","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.bbadva.2026.100199_bib0047","doi-asserted-by":"crossref","DOI":"10.3390\/cells10092198","article-title":"Down the iron path: mitochondrial iron homeostasis and beyond","volume":"10","author":"Dietz","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.bbadva.2026.100199_bib0048","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/17474086.2016.1268047","article-title":"Mitochondria and iron: current questions","volume":"10","author":"Paul","year":"2017","journal-title":"Expert Rev. Hematol."},{"issue":"5","key":"10.1016\/j.bbadva.2026.100199_bib0049","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/s41422-022-00653-7","article-title":"Cuproptosis: a copper-triggered modality of mitochondrial cell death","volume":"32","author":"Tang","year":"2022","journal-title":"Cell Res."},{"issue":"5","key":"10.1016\/j.bbadva.2026.100199_bib0050","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bbadva.2026.100199_bib0051","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","article-title":"Ferroptosis: molecular mechanisms and health implications","volume":"31","author":"Tang","year":"2021","journal-title":"Cell Res."},{"issue":"11","key":"10.1016\/j.bbadva.2026.100199_bib0052","doi-asserted-by":"crossref","DOI":"10.1016\/j.mocell.2025.100276","article-title":"Brief guide to detecting ferroptosis","volume":"48","author":"Thi Nghiem","year":"2025","journal-title":"Mol. Cells"},{"issue":"1\u20132","key":"10.1016\/j.bbadva.2026.100199_bib0053","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bbadva.2026.100199_bib0054","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nchembio.2239","article-title":"ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition","volume":"13","author":"Doll","year":"2017","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"10.1016\/j.bbadva.2026.100199_bib0055","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nchembio.2238","article-title":"Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis","volume":"13","author":"Kagan","year":"2017","journal-title":"Nat. Chem. Biol."},{"issue":"12","key":"10.1016\/j.bbadva.2026.100199_bib0056","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/ncb3064","article-title":"Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice","volume":"16","author":"Friedmann Angeli","year":"2014","journal-title":"Nat. Cell Biol."},{"issue":"3","key":"10.1016\/j.bbadva.2026.100199_bib0057","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","article-title":"Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018","volume":"25","author":"Galluzzi","year":"2018","journal-title":"Cell Death Differ."},{"issue":"7860","key":"10.1016\/j.bbadva.2026.100199_bib0058","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","article-title":"DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer","volume":"593","author":"Mao","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.bbadva.2026.100199_bib0059","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103788","article-title":"DHODH-mediated mitochondrial redox homeostasis: a novel ferroptosis regulator and promising therapeutic target","volume":"85","author":"Cao","year":"2025","journal-title":"Redox Biol."},{"key":"10.1016\/j.bbadva.2026.100199_bib0060","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.54166","article-title":"Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis","volume":"9","author":"Nassar","year":"2020","journal-title":"Elife"},{"issue":"14","key":"10.1016\/j.bbadva.2026.100199_bib0061","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1158\/0008-5472.CAN-23-1489","article-title":"ACSM1 and ACSM3 regulate fatty acid metabolism to support prostate cancer growth and constrain ferroptosis","volume":"84","author":"Shrestha","year":"2024","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bbadva.2026.100199_bib0062","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/s41467-025-56494-6","article-title":"VSTM2L protects prostate cancer cells against ferroptosis via inhibiting VDAC1 oligomerization and maintaining mitochondria homeostasis","volume":"16","author":"Yang","year":"2025","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.bbadva.2026.100199_bib0063","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41589-022-01159-4","article-title":"Functional spectrum and specificity of mitochondrial ferredoxins FDX1 and FDX2","volume":"19","author":"Schulz","year":"2023","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bbadva.2026.100199_bib0064","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103930","article-title":"Ferredoxins: master regulators in mitochondrial redox homeostasis and programmed cell death","volume":"88","author":"Lu","year":"2025","journal-title":"Redox Biol."},{"issue":"26","key":"10.1016\/j.bbadva.2026.100199_bib0065","doi-asserted-by":"crossref","first-page":"11775","DOI":"10.1073\/pnas.1004250107","article-title":"Humans possess two mitochondrial ferredoxins, Fdx1 and Fdx2, with distinct roles in steroidogenesis, heme, and Fe\/S cluster biosynthesis","volume":"107","author":"Sheftel","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.bbadva.2026.100199_bib0066","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2216722120","article-title":"FDX1-dependent and independent mechanisms of elesclomol-mediated intracellular copper delivery","volume":"120","author":"Zulkifli","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"13","key":"10.1016\/j.bbadva.2026.100199_bib0067","doi-asserted-by":"crossref","first-page":"5713","DOI":"10.1021\/jacs.1c13626","article-title":"Protein-interaction affinity gradient drives [4Fe-4S] cluster insertion in human lipoyl synthase","volume":"144","author":"Saudino","year":"2022","journal-title":"J. Am. Chem. Soc."},{"issue":"20","key":"10.1016\/j.bbadva.2026.100199_bib0068","doi-asserted-by":"crossref","first-page":"8344","DOI":"10.1073\/pnas.0812808106","article-title":"The iron-sulfur clusters of dehydratases are primary intracellular targets of copper toxicity","volume":"106","author":"Macomber","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.bbadva.2026.100199_bib0069","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118867","article-title":"Getting out what you put in: copper in mitochondria and its impacts on human disease","volume":"1868","author":"Cobine","year":"2021","journal-title":"Biochim. Biophys. Acta Mol. Cell. Res."},{"issue":"7682","key":"10.1016\/j.bbadva.2026.100199_bib0070","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nature24637","article-title":"NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis","volume":"551","author":"Alvarez","year":"2017","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.bbadva.2026.100199_bib0071","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107678","article-title":"FDX2, an iron-sulfur cluster assembly factor, is essential to prevent cellular senescence, apoptosis or ferroptosis of ovarian cancer cells","volume":"300","author":"Miyahara","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadva.2026.100199_bib0072","article-title":"Ferredoxin 1 is a cuproptosis-key gene responsible for tumor immunity and drug sensitivity: a pan-cancer analysis","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbadva.2026.100199_bib0073","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2020.11.024","article-title":"Membrane damage during ferroptosis is caused by oxidation of phospholipids catalyzed by the oxidoreductases POR and CYB5R1","volume":"81","author":"Yan","year":"2021","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.bbadva.2026.100199_bib0074","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s00018-024-05358-1","article-title":"Mitochondrial copper overload promotes renal fibrosis via inhibiting pyruvate dehydrogenase activity","volume":"81","author":"Zhu","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"issue":"30","key":"10.1016\/j.bbadva.2026.100199_bib0075","doi-asserted-by":"crossref","first-page":"11568","DOI":"10.1074\/jbc.RA119.009037","article-title":"Cardiolipin-induced activation of pyruvate dehydrogenase links mitochondrial lipid biosynthesis to TCA cycle function","volume":"294","author":"Li","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadva.2026.100199_bib0076","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2026.108087","article-title":"FASN targeting by G28UCM impairs mitochondrial fatty acid synthesis and reveals a FASN-SDHB synthetic interaction","volume":"224","author":"Wilfinger-Lutz","year":"2026","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.bbadva.2026.100199_bib0077","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s41419-026-08462-1","article-title":"PDHA1-acetylation signaling suppresses cuproptosis to attenuate anti-androgen effect in prostate cancer","volume":"17","author":"Zhuang","year":"2026","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbadva.2026.100199_bib0078","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1633891","article-title":"Ginsenoside Rh2 repressed the progression of prostate cancer through the mitochondrial damage induced by mitophagy and ferroptosis","volume":"15","author":"He","year":"2025","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.bbadva.2026.100199_bib0079","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1186\/s12877-025-06237-5","article-title":"AIMP1 exerts hearing protection role in age related hearing loss mice by regulating SIRT1 expression","volume":"25","author":"Peng","year":"2025","journal-title":"BMC Geriatr."},{"key":"10.1016\/j.bbadva.2026.100199_bib0080","doi-asserted-by":"crossref","DOI":"10.1177\/09603271251335393","article-title":"Hypoxia-induced autophagy attenuates ferredoxin 1-mediated cuproptosis in colorectal cancer cells","volume":"44","author":"Qin","year":"2025","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.bbadva.2026.100199_bib0081","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jot.2025.01.011","article-title":"Fibroblast growth factor receptor 3 mutation promotes HSPB6-mediated cuproptosis in hypochondroplasia by impairing chondrocyte autophagy","volume":"51","author":"Chen","year":"2025","journal-title":"J. Orthop. Translat."},{"issue":"7","key":"10.1016\/j.bbadva.2026.100199_bib0082","doi-asserted-by":"crossref","first-page":"7213","DOI":"10.1021\/acsnano.4c16981","article-title":"Nanovesicles for lipid metabolism reprogram-enhanced ferroptosis and magnetotherapy of refractory tumors and inhibiting metastasis with activated innate immunity","volume":"19","author":"Cheng","year":"2025","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.bbadva.2026.100199_bib0083","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/s13577-023-00896-5","article-title":"Mitochondrial transfer in PC-3 cells fingerprinted in ferroptosis sensitivity: a brand new approach targeting cancer metabolism","volume":"36","author":"Nikoo","year":"2023","journal-title":"Hum. Cell"},{"issue":"34","key":"10.1016\/j.bbadva.2026.100199_bib0084","doi-asserted-by":"crossref","first-page":"48017","DOI":"10.1021\/acsami.5c11373","article-title":"Ultrasound-driven Cu-nanobots for tumor deep penetration and induction of cuproptosis in prostate cancer therapy","volume":"17","author":"Xu","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"10.1016\/j.bbadva.2026.100199_bib0085","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13046-023-02720-2","article-title":"Ferroptosis inducers enhanced cuproptosis induced by copper ionophores in primary liver cancer","volume":"42","author":"Wang","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"23","key":"10.1016\/j.bbadva.2026.100199_bib0086","article-title":"Nanoparticles synergize ferroptosis and cuproptosis to potentiate cancer immunotherapy","volume":"11","author":"Li","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"1","key":"10.1016\/j.bbadva.2026.100199_bib0087","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/s41467-017-01497-1","article-title":"Structure and functional dynamics of the mitochondrial Fe\/S cluster synthesis complex","volume":"8","author":"Boniecki","year":"2017","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.bbadva.2026.100199_bib0088","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105046","article-title":"FDX1 regulates cellular protein lipoylation through direct binding to LIAS","volume":"299","author":"Dreishpoon","year":"2023","journal-title":"J. Biol. Chem."},{"issue":"37","key":"10.1016\/j.bbadva.2026.100199_bib0089","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abm9427","article-title":"Eprenetapopt triggers ferroptosis, inhibits NFS1 cysteine desulfurase, and synergizes with serine and glycine dietary restriction","volume":"8","author":"Fujihara","year":"2022","journal-title":"Sci. Adv."}],"container-title":["BBA Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667160326000207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667160326000207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:24:57Z","timestamp":1787585097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667160326000207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":89,"alternative-id":["S2667160326000207"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadva.2026.100199","relation":{},"ISSN":["2667-1603"],"issn-type":[{"value":"2667-1603","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitochondrial convergence of ferroptosis and cuproptosis in castration-resistant prostate cancer: From metabolic vulnerabilities to therapeutic targeting","name":"articletitle","label":"Article Title"},{"value":"BBA Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadva.2026.100199","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100199"}}